MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Relationship of health-related quality of life (HRQoL) patterns with clinical diagnosis in patients with spinocerebellar ataxia (SCA) – A latent class analysis

    M. Buchholz, N. Weber, T. Klockgether, B. Michalowsky (Greifswald, Germany)

    Objective: The aim was to identify patterns of the EQ-5D-3L in patients with SCA to describe the relationship between the patient’s diagnosis and clinical parameters.…
  • 2023 International Congress

    Novelty Seeking: A Narrative Review

    K. Paulk, L. Neilson (Portland, USA)

    Objective: To explore novelty seeking (NS) as a construct, in both its adaptive and maladaptive roles, in order to provide insight into the cognitive and…
  • 2023 International Congress

    Epigenome-wide meta-analysis of sex-differential DNA methylation in Parkinson’s disease

    T. Yang, C. Li, Q. Wei, R. Ou, Y. Cheng, K. Liu, J. Lin, Y. Xiao, H. Shang (Chengdu, China)

    Objective: To comprehensively characterize the blood-based DNA methylation alterations related to sex in patients with Parkinson's disease (PD), shedding light on the underlying genes and…
  • 2023 International Congress

    Effects of cerebellar theta burst stimulation on working memory in Parkinson’s disease

    N. Raies, J-F. Nankoo, T. Grippe, R. Chen (Toronto, Canada)

    Objective: This study aims to investigate the effects of cerebellar theta burst stimulation (TBS) on working memory (WM) performance in patients with Parkinson’s disease (PD)…
  • 2023 International Congress

    Glunomab: a novel therapeutics for the treatment of Parkinson’s Disease

    D. Torrente, E. Su, GP. Schielke, M. Warnock, T. Stevenson, K. Mann, F. Lesept, N. Delétage, M. Blanc, D. Vivien, D. Lawrence (Ann Arbor, USA)

    Objective: The focus of this study was: 1) to characterize the expression and the localization of an endogenous protease, tissue plasminogen activator (tPA) in the…
  • 2023 International Congress

    Short-term, intermittent exercise program improved the balance and gait in patients with Parkinson’s disease

    YC. Chein, JC. Hsu, KH. Chen, HY. Chen, CF. Lo, WE. Lee (Hsinchu City, Taiwan)

    Objective: To explore the effects of a short-term, intermittent exercise program combined dynamic movement and core muscle training on balance and gait in patients with…
  • 2023 International Congress

    Cortical thickness and global atrophy progression in Parkinson’s disease with probable RBD

    J. Oltra, A. Campabadal, C. Uribe, J. Pardo, I. Roura, MJ. Martí, Y. Compta, F. Valldeoriola, N. Bargallo, A. Iranzo, C. Junque, B. Segura (Barcelona, Spain)

    Objective: To explore 3-year cortical thickness (CTh) and global atrophy progression in treated Parkinson’s disease (PD) with probable REM sleep behavior disorder (RBD). Background: Parkinson’s…
  • 2023 International Congress

    The association between compliance and the effects of home-based touchscreen training in Parkinson’s disease

    J. de Vleeschhauwer, E. Nackaerts, Y. Zhang, L. Janssens, W. Vandenberghe, A. Nieuwboer (Leuven, Belgium)

    Objective: To explore whether training success is determined by compliance as well as by cognitive function, depression and levodopa equivalent dosage (LEDD). Background: Training compliance…
  • 2023 International Congress

    Functional network correlates of APOE ε4 allele in Parkinson’s disease

    K. Schindlbeck, A. Vo, P. Mattis, N. Nguyen, D. Eidelberg (Munich, Germany)

    Objective: To investigate the influence of APOE ε4 allele on metabolic network activity and functional connectivity in patients with Parkinson's disease (PD). Background: Disease progression…
  • 2023 International Congress

    Lysosomal-driven reduction of alpha-synuclein aggregates in a neuron-like model of Parkinson’s disease

    S. Lucas-Del-Pozo, G. Uras, F. Fierli, AHV. Schapira (London, United Kingdom)

    Objective: To test whether PIKfyve inhibition results in a lysosomal-driven reduction of alpha-synuclein aggregates in a mutant neuroblastoma cell line overexpressing an aggregation-prone form of…
  • « Previous Page
  • 1
  • …
  • 385
  • 386
  • 387
  • 388
  • 389
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley